Teresa C. Dugger - Concepedia

Author

Teresa C. Dugger

Vanderbilt University

Also Known As

T C Dugger, T Dugger, T. C. Dugger, T. Dugger, Teresa C Dugger, Teresa C. Dugger, Teresa Dugger

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Vanderbilt-Ingram Cancer Center Breast Cancer Research Foundation Vanderbilt University Medical Center Biogen (United States)

About

Teresa C. Dugger is an author at Vanderbilt University specializing in tumor biology, medicine, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.1K
2	Cell Biology	7	7	1.1K
3	Immunology	6	6	1.1K
4	Pharmacology	2	2	22
5	Pathology	1	1	10

Teresa C. Dugger

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer Neil E. Bhola, Justin M. Balko, Teresa C. Dugger, Journal of Clinical Investigation	2013	586
Human Breast Cancer Cells Selected for Resistance to Trastuzumab <i>In vivo</i> Overexpress Epidermal Growth Factor Receptor and ErbB Ligands and Remain Dependent on the ErbB Receptor Network Christoph A. Ritter, Marianela Pérez-Torres, Cammie Rinehart, Clinical Cancer Research	2007	497
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases Rebecca S. Muraoka, Nancy Dumont, Christoph A. Ritter, Journal of Clinical Investigation Soluble FcMedicineImmunologyCancer Cell BiologyImmune Checkpoint Inhibitor	2002	485
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases Rebecca S. Muraoka, Nancy Dumont, Christoph A. Ritter, Journal of Clinical Investigation Breast Cancer MetastasesSoluble FcCancer ImmunosurveillanceMedicineTgf-β Signaling	2002	413
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer Luigi Formisano, Yao Lu, Alberto Servetto, Nature Communications	2019	383
Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression Swati Biswas, Marta Guix, Cammie Rinehart, Journal of Clinical Investigation	2007	338
Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast Cancer Valerie M. Jansen, Neil E. Bhola, Joshua A. Bauer, Cancer Research	2017	224
Early Changes in Protein Expression Detected by Mass Spectrometry Predict Tumor Response to Molecular Therapeutics Michelle L. Reyzer, Robert L. Caldwell, Teresa C. Dugger, Cancer Research	2004	149
Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells Todd W. Miller, James T. Forbes, Chirayu Shah, Clinical Cancer Research	2009	131
Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer Luigi Formisano, Kimberly M. Stauffer, Christian D. Young, Clinical Cancer Research	2017	123

Page 1